Pharmaceutical News

RSS

Study examines unnecessary medicine use in patients with advanced lung cancer

Individuals with advanced lung cancer often have other comorbid conditions, and many may be on complex, costly, and even inappropriate medication regimens.

6 Sep 2018

Bee venom may be effective treatment for eczema

Bee venom and its major component, melittin, may be effective treatments for atopic dermatitis (or eczema), according to a British Journal of Pharmacology study.

6 Sep 2018

Cannabis users experience increased cortical activation during the brain's resting state

Recent research from the Center for BrainHealth at The University of Texas at Dallas shows that cannabis users experience increased cortical activation during the brain's resting state when compared with nonusers.

6 Sep 2018

Medical marijuana may alter brain connections to provide relief from chronic nerve pain

When medical marijuana is taken for chronic nerve pain, it may provide pain relief by reducing connections between the areas of the brain that process emotions and sensory signals, according to a study published in the September 5, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.

6 Sep 2018

Hypertension drugs may be used to preserve memory of lupus patients

Researchers from The Feinstein Institute for Medical Research have discovered that the activation of brain cells called microglia likely contributes to the memory loss and other cognitive impairments suffered by many patients with systemic lupus erythematosus.

5 Sep 2018

UQ drug expert supports current medicinal cannabis policies in Australia

Cannabis-based medicines should only be used under medical supervision until clinical studies have assessed their safety and efficacy, a University of Queensland drug expert has cautioned.

5 Sep 2018

Study: Many patients want more information about their medicines

Many patients want more information on the medicines they're prescribed and greater say in the brands they use, the first major study of the burden of long-term medicine use has concluded.

5 Sep 2018

Effective vaccines for world's most prevalent infectious diseases are missing from pipeline

Many of the vaccines critically needed to fight some of the world's most prevalent infectious diseases are not likely to be developed, a new analysis of current candidates in the research and development pipeline has found.

5 Sep 2018

Powerful antioxidant can lower the risk of second heart attack or stroke

Doctors have long known that in the months after a heart attack or stroke, patients are more likely to have another attack or stroke. Now, a paper in the Journal of the American College of Cardiology explains what happens inside blood vessels to increase risk - and suggests a new way to treat it.

5 Sep 2018

Anti-inflammatory use during surgery may lead to improved outcomes for cancer patients

The world's first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in colon cancer patients to improve their cancer outcome has been published in scientific journal, BMC Cancer.

4 Sep 2018

International collaboration project to enhance drug safety in East Africa

In recent years access to drugs and vaccines has been increasing in many African countries, but the systems for monitoring treatment effects and reporting side-effects require further development. Karolinska Institutet will now lead an international collaboration project on pharmacovigilance - drugs safety - in four countries in East Africa.

4 Sep 2018

UCLA biologists find 8,000 new antibiotic combinations to be effective

Scientists have traditionally believed that combining more than two drugs to fight harmful bacteria would yield diminishing returns.

3 Sep 2018

FDA recalls montelukast tablets by Camber Pharmaceuticals due to drug mix-up

The U.S. Food and Drug Administration is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 – by Camber Pharmaceuticals, Inc., Piscataway, N.J. Sealed bottles labeled as montelukast sodium tablets, 10 milligram, 30-count bottle from Camber were found to instead contain 90 tablets of Losartan Potassium Tablets, 50 mg.

3 Sep 2018

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter for the New Drug Application for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder.

3 Sep 2018

New Euro-GASP program monitors continued effectiveness of treatment regimen for gonorrhea

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme.

31 Aug 2018

Subcutaneous injection of new protein helps treat hemophilia more effectively

Patients with hemophilia bleed spontaneously or following trauma. The most common sites of bleeding are into joints, but bleeds can also happen into any tissue in the body including the muscles, brain, or eyes.

31 Aug 2018

Single dose of cannabidiol showed effective results in rats with symptoms of depression

Commercial antidepressants typically take two to four weeks to have a significant effect on a depressed patient. They are also inneffective in approximately 40% of the cases.

31 Aug 2018

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.

30 Aug 2018

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

30 Aug 2018

EC grants marketing authorization for ONPATTRO (patisiran) in Europe

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the European Commission (EC) has granted marketing authorization for ONPATTRO (patisiran) for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis in adults with stage 1 or stage 2 polyneuropathy.

30 Aug 2018

Pharmaceutical News

Study examines unnecessary medicine use in patients with advanced lung cancer

Bee venom may be effective treatment for eczema

Cannabis users experience increased cortical activation during the brain's resting state

Medical marijuana may alter brain connections to provide relief from chronic nerve pain

Hypertension drugs may be used to preserve memory of lupus patients

UQ drug expert supports current medicinal cannabis policies in Australia

Study: Many patients want more information about their medicines

Effective vaccines for world's most prevalent infectious diseases are missing from pipeline

Powerful antioxidant can lower the risk of second heart attack or stroke

Anti-inflammatory use during surgery may lead to improved outcomes for cancer patients

International collaboration project to enhance drug safety in East Africa

UCLA biologists find 8,000 new antibiotic combinations to be effective

FDA recalls montelukast tablets by Camber Pharmaceuticals due to drug mix-up

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

New Euro-GASP program monitors continued effectiveness of treatment regimen for gonorrhea

Subcutaneous injection of new protein helps treat hemophilia more effectively

Single dose of cannabidiol showed effective results in rats with symptoms of depression

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

EC grants marketing authorization for ONPATTRO (patisiran) in Europe

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Latest News